Vivimed Labs

Vivimed Labs Limited is an India-based specialty-chemicals and pharmaceutical company headquartered in Hyderabad. Its business has historically combined two principal areas: specialty chemicals for home and personal care, and healthcare products based on active pharmaceutical ingredients and finished formulations. The company has also operated in hair dyes, imaging chemicals, photochromic materials, and related technical products. The business began in 1988 as M/s Emgi Pharmaceuticals & Chemicals Private Limited. It was founded by Dr. V. Manohar Rao, who later served as chairman of Vivimed Labs. The company adopted the Vivimed Labs name in 1997, as it expanded beyond its original healthcare orientation. A significant turning point came with its entry into the home and personal care sector through triclosan, an antimicrobial ingredient used in formulated consumer and industrial products. During the early 2000s, the company broadened its specialty-chemicals portfolio to include ingredients for skin care, sun protection, hair care, oral care, preservation, and antimicrobial applications. Vivimed became publicly listed in India in 2005 on the BSE and NSE. In 2007, VVS Pharma, a sister company operating in pharmaceuticals and healthcare, merged with Vivimed Labs. The resulting business retained distinct specialty-chemicals and healthcare activities, with Santosh Varalwar associated with the specialty-chemicals division and Sandeep Varalwar associated with healthcare operations. The group pursued international expansion through acquisitions. In 2008 it acquired James Robinson, a long-established manufacturer of hair dyes, fluorescent materials, solvent-ink dye markers, and photochromics. James Robinson initially continued to operate independently, before being integrated into the Vivimed Group in 2010 and renamed Vivimed Labs Europe in April of that year. The acquired business contributed the Jarocol hair-dye range and Reversacol photochromic-dye range, both of which were retained. Its photochromics and hair-dye research capability included a kilo laboratory in Huddersfield, United Kingdom, while manufacturing activity was shifted from Germany to Hyderabad. Dr. Richard Smith, who had been managing director of James Robinson, became chief operating officer of Vivimed Labs. In 2009, Vivimed acquired Har-Met, a specialty-chemicals distributor based in Pennsylvania. Har-Met was incorporated as Vivimed Labs USA Inc. in 2010 and operated as a separate strategic business unit serving the United States and neighboring markets. The United States was described as particularly important for the group's home and personal care activities. Vivimed Health Care represented the pharmaceutical side of the company. Its activities included manufacturing APIs and finished formulations, supported by production facilities in Haridwar, Kashipur, and Hyderabad and research and development in Hyderabad. Its healthcare products were associated with therapeutic and public-health areas including diabetes, nutritional supplementation, tuberculosis, oncology, hygiene, and infectious diseases. The division's principal export markets were described as countries of the former Soviet Union and African markets. The available reference material documents the company's historical structure, acquisitions, product areas, and international footprint, but does not establish its current operating status, ownership, financial condition, website, or present management. Those fields therefore require verification against current corporate, regulatory, exchange, or insolvency records.

Vivimed Labs was incorporated in 1988 as M/s Emgi Pharmaceuticals & Chemicals Private Limited under the leadership of founder Dr. V. Manohar Rao. The original business was focused primarily on healthcare and pharmaceuticals. In 1997, the company changed its name to Vivimed Labs Limited and began developing a broader specialty-chemicals platform. The company's move into home and personal care was associated with its manufacture and supply of triclosan, an antimicrobial ingredient. From 2002, Vivimed expanded its range in response to growth in the home and personal care chemicals market. Its portfolio came to cover sunscreen, anti-wrinkle, skin-lightening, preservation, anti-dandruff, hair-growth, conditioning, antimicrobial, and oral-care applications. Vivimed was listed on the Bombay Stock Exchange and the National Stock Exchange of India in 2005. In 2007, VVS Pharma, a sister company active in pharmaceutical and healthcare products, merged with Vivimed Labs. The group maintained specialty-chemicals and healthcare divisions after the combination. Santosh Varalwar was associated with the specialty-chemicals division, while Sandeep Varalwar led the healthcare division. International expansion accelerated through acquisitions. In 2008, Vivimed acquired James Robinson, a long-established company with activities in hair dyes, fluorescent chemicals, solvent-ink dye markers, imaging-related materials, and photochromics. James Robinson continued to function independently for a period after the acquisition and was absorbed into the Vivimed Group in 2010. In April 2010, it was renamed Vivimed Labs Europe. The Jarocol and Reversacol names were retained for hair-dye and photochromic products respectively. Dr. Richard Smith, James Robinson's managing director before and during the transaction, became Vivimed Labs' chief operating officer. Manufacturing was moved from Germany to Hyderabad, while a kilo laboratory for photochromic and hair-dye research remained in Huddersfield, United Kingdom. Vivimed acquired Har-Met, a specialty-chemicals distributor based in Pennsylvania, in 2009. In 2010, Har-Met was incorporated as Vivimed Labs USA Inc. and operated as a separate American strategic business unit. This gave the group a dedicated presence in the United States, described as its largest home and personal care market, as well as in neighboring countries. The healthcare division manufactured both APIs and finished formulations. Its production footprint included facilities in Haridwar, Kashipur, and Hyderabad, with research and development in Hyderabad. Its stated healthcare markets included countries of the former Soviet Union and Africa, and its product areas included diabetes, nutritional supplements, tuberculosis, oncology, hygiene, and infectious diseases. The available reference material provides a historical account through the group's acquisitions and divisional structure, but does not document subsequent ownership changes, financial performance, current leadership, or whether the company remains actively operating. These matters remain to be reviewed using current authoritative records.

1. 2010Integration of international chemical businesses

   James Robinson was integrated into the Vivimed Group and renamed Vivimed Labs Europe; Har-Met became Vivimed Labs USA Inc.

   Source
2. 2009Har-Met acquisition

   Vivimed acquired Har-Met, a Pennsylvania-based specialty-chemicals distributor.

   Source
3. 2008James Robinson acquisition

   Vivimed acquired James Robinson, adding hair dyes, imaging chemicals, fluorescent materials, solvent-ink dye markers, and photochromics.

   Source
4. 2007VVS Pharma merger

   VVS Pharma, a sister company in pharmaceuticals and healthcare, merged with Vivimed Labs.

   Source
5. 2005Indian stock-market listing

   Vivimed Labs became listed on the Bombay Stock Exchange and National Stock Exchange of India.

   Source
6. 2002Expansion into broader home and personal care chemicals

   Vivimed diversified its specialty-chemicals portfolio into additional home and personal care applications.

   Source
7. 1997Renamed Vivimed Labs

   The company adopted the Vivimed Labs Limited name and began expanding beyond its earlier healthcare focus.

   Source
8. 1988Original incorporation

   The company was incorporated as M/s Emgi Pharmaceuticals & Chemicals Private Limited, founded by Dr. V. Manohar Rao.

   Source

A diversified B2B supplier combining specialty ingredients for home and personal care with pharmaceutical APIs, finished formulations, hair-color chemistry, imaging materials, and photochromic technologies.

• TriclosanAntimicrobial specialty chemical1997

  Vivimed's entry point into the home and personal care chemicals market was associated with the manufacture and supply of triclosan. The ingredient was positioned for antimicrobial use in formulated products and helped establish the company's specialty-chemicals business before it expanded into a wider range of personal-care ingredients.

• Home and personal care ingredientsSpecialty chemicals2002

  The portfolio covered ingredients and actives for sunscreen, anti-wrinkle, skin-lightening, preservation, anti-dandruff, hair-growth, hair-conditioning, antimicrobial, and oral-care formulations. These products were supplied primarily as business-to-business inputs rather than as a single consumer-facing brand.

• JarocolHair dyes

  Jarocol was the retained James Robinson product name for hair-dye materials after Vivimed's acquisition and subsequent integration of the British-origin specialty-chemicals business. The range formed part of Vivimed's professional and industrial hair-color chemistry offering.

• ReversacolPhotochromic dyes

  Reversacol was the retained James Robinson name for photochromic dyes. The product line added light-responsive materials to Vivimed's portfolio and was supported by research capability, including a kilo laboratory in Huddersfield, United Kingdom.

• Imaging and fluorescent chemicalsSpecialty chemicals

  Through the James Robinson business, Vivimed supplied imaging chemicals, fluorescent materials, and solvent-ink dye markers. These products complemented the group's hair-color and photochromic activities and broadened its industrial specialty-chemicals scope.

• Vivimed Health Care APIs and formulationsPharmaceuticals

  Vivimed Health Care manufactured active pharmaceutical ingredients and finished formulations. Its stated therapeutic and public-health areas included diabetes, nutritional supplements, tuberculosis, oncology, hygiene, and infectious diseases, with production in northern and southern India and research and development in Hyderabad.

• 2009Acquisition of Har-MetM&A

  Vivimed pursued a stronger distribution presence in North America, particularly for its home and personal care chemicals.

  What changed. The company acquired Har-Met, a specialty-chemicals distributor based in Pennsylvania.

  Aftermath. Har-Met was incorporated as Vivimed Labs USA Inc. in 2010 and operated as a separate American strategic business unit.

  Source
• 2008Acquisition of James RobinsonM&A

  Vivimed sought to extend its specialty-chemicals capabilities into hair dyes, imaging materials, fluorescent chemicals, and photochromics through the acquisition of the long-established James Robinson business.

  What changed. Vivimed acquired James Robinson while initially allowing it to operate independently. The business was later integrated into the group and renamed Vivimed Labs Europe in 2010.

  Aftermath. The acquisition added the Jarocol and Reversacol product names and retained a photochromic and hair-dye research laboratory in Huddersfield, while manufacturing was shifted from Germany to Hyderabad.

  Source

1. Vivimed Labs